506 related articles for article (PubMed ID: 27135726)
1. Does Carbohydrate Challenge Testing Predict Clinical Response in Small Intestinal Bacterial Overgrowth?
Long SK; Di Palma JA
South Med J; 2016 May; 109(5):296-9. PubMed ID: 27135726
[TBL] [Abstract][Full Text] [Related]
2. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
[TBL] [Abstract][Full Text] [Related]
3. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.
Zhao J; Zheng X; Chu H; Zhao J; Cong Y; Fried M; Fox M; Dai N
Neurogastroenterol Motil; 2014 Jun; 26(6):794-802. PubMed ID: 24641100
[TBL] [Abstract][Full Text] [Related]
4. Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome.
Kasir R; Zakko S; Zakko P; Adler M; Lee A; Dhingra S; Guttermuth C
Dig Dis Sci; 2016 Mar; 61(3):846-51. PubMed ID: 26362282
[TBL] [Abstract][Full Text] [Related]
5. Preferential usage of rifaximin for the treatment of hydrogen-positive smallintestinal bacterial overgrowth.
Barkin JA; Keihanian T; Barkin JS; Antequera CM; Moshiree B
Rev Gastroenterol Peru; 2019; 39(2):111-115. PubMed ID: 31333225
[TBL] [Abstract][Full Text] [Related]
6. Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery.
Petrone P; Sarkisyan G; Fernández M; Coloma E; Akopian G; Ortega A; Kaufman HS
Arch Surg; 2011 Apr; 146(4):444-7. PubMed ID: 21502453
[TBL] [Abstract][Full Text] [Related]
7. Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy.
Saad RJ; Chey WD
Clin Gastroenterol Hepatol; 2014 Dec; 12(12):1964-72; quiz e119-20. PubMed ID: 24095975
[TBL] [Abstract][Full Text] [Related]
8. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome.
Tuteja AK; Talley NJ; Stoddard GJ; Verne GN
Dig Dis Sci; 2019 Mar; 64(3):838-845. PubMed ID: 30370492
[TBL] [Abstract][Full Text] [Related]
9. [The dietary features of diarrhea predominant irritable bowel syndrome patients with small intestinal bowel overgrowth].
Wei H; Liu ZJ; Wang K; Zheng W; Duan LP
Zhonghua Nei Ke Za Zhi; 2017 Aug; 56(8):567-571. PubMed ID: 28789488
[No Abstract] [Full Text] [Related]
10. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture.
Ghoshal UC; Srivastava D; Ghoshal U; Misra A
Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):753-60. PubMed ID: 24849768
[TBL] [Abstract][Full Text] [Related]
11. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?
Reddymasu SC; Sostarich S; McCallum RW
BMC Gastroenterol; 2010 Feb; 10():23. PubMed ID: 20175924
[TBL] [Abstract][Full Text] [Related]
12. Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial.
Majewski M; McCallum RW
Adv Med Sci; 2007; 52():139-42. PubMed ID: 18217406
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome.
Ning Y; Lou C; Huang Z; Chen D; Huang H; Chen L; Zhang B; Dai N; Zhao J; Zhen X
Hell J Nucl Med; 2016; 19(2):124-9. PubMed ID: 27331205
[TBL] [Abstract][Full Text] [Related]
14. Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome.
Zhuang X; Tian Z; Luo M; Xiong L
BMC Gastroenterol; 2020 Jun; 20(1):187. PubMed ID: 32532214
[TBL] [Abstract][Full Text] [Related]
15. The relationship between small intestinal bacterial overgrowth and irritable bowel syndrome.
Ding XW; Liu YX; Fang XC; Liu K; Wei YY; Shan MH
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5191-5196. PubMed ID: 29228433
[TBL] [Abstract][Full Text] [Related]
16. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy.
Ghoshal UC; Shukla R; Ghoshal U
Gut Liver; 2017 Mar; 11(2):196-208. PubMed ID: 28274108
[TBL] [Abstract][Full Text] [Related]
17. Obesity Is Inversely Related to Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Non-Constipation Irritable Bowel Syndrome.
Jung SE; Joo NS; Han KS; Kim KN
J Korean Med Sci; 2017 Jun; 32(6):948-953. PubMed ID: 28480652
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain.
Collins BS; Lin HC
J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):382-6. PubMed ID: 21240023
[TBL] [Abstract][Full Text] [Related]
19. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
Rana SV; Sharma S; Kaur J; Sinha SK; Singh K
Digestion; 2012; 85(3):243-7. PubMed ID: 22472730
[TBL] [Abstract][Full Text] [Related]
20. Determination of rifaximin treatment period according to lactulose breath test values in nonconstipated irritable bowel syndrome subjects.
Bae S; Lee KJ; Kim YS; Kim KN
J Korean Med Sci; 2015 Jun; 30(6):757-62. PubMed ID: 26028929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
